Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy

Blood Adv. 2024 Mar 18:bloodadvances.2024012573. doi: 10.1182/bloodadvances.2024012573. Online ahead of print.
No abstract available